Panbela
is a Minnesota-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and orphan diseases... Read morePanbela
is a Minnesota-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer and orphan diseases... Read more
2011
PublicIndependent CompanyNASDAQPBLA
News
Nov 14, 2024
Seeking Alpha
Panbela: Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript
Sep 24, 2024
GlobalNewswire
Press Release: Panbela : First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
Jul 30, 2024
Benzinga
Panbela: Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
Jun 24, 2024
GlobalNewswire
Press Release: Panbela : Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
Jun 10, 2024
GlobalNewswire
Press Release: Panbela : Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
Jun 10, 2024
MarketScreener
Panbela: Panbela Announces Oral Presentation at Digestive Disease Week (DDW)
May 15, 2024
Seeking Alpha
Panbela: Panbela Therapeutics GAAP EPS of -$2.28
May 15, 2024
GlobeNewswire
Press Release: Panbela : Panbela Provides Business Update and Reports Q1 2024 Financial Results
May 15, 2024
Seeking Alpha
Panbela: Panbela Therapeutics, Inc. (PBLA) Q1 2024 Earnings Call Transcript
May 06, 2024
GlobalNewswire
Press Release: Panbela : Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac
Panbela Competitors
1
2
3
4
5
6
7
8
9
10